Abstract In 1874, Karl Kahlbaum described catatonia as an independent syndrome
characterized by motor, affective, and behavioral anomalies. In the following years, various …

Background Catatonia is a complex psychomotor disorder characterized by motor, affective,
and behavioral symptoms. Despite being known for almost 150 years, its pathomechanisms …

Introduction The world is currently undergoing an extremely stressful scenario due to the
COVID-19 pandemic. This unexpected and dramatic situation could increase the incidence …

The effect of lorazepam in the treatment of catatonia is outstanding and almost immediate.
Clinicians are familiar with its effects: mute patients can speak again, akinetic patients can …

The difficulty in studying the relationship between stress and emotional regulation is due to
the need to contemplate a dynamic perspective that analyzes the moderating role of stress …

Since January 1st 2022, catatonia is (again) recognized as an independent diagnostic entity
in the 11th revision of the International Classification of Diseases (ICD-11). This is a relevant …

Background Inflammation is a potential risk factor of mental disturbance. FKBP5 that
encodes FK506-binding protein 51 (FKBP51), a negative cochaperone of glucocorticoid …

A variety of neurological and psychiatric disorders have recently been shown to be highly
associated with the abnormal development and function of oligodendrocytes (OLs) and …

This study aimed to characterize the clinical profile of patients with brief psychotic disorders
(BPD) triggered by the psychosocial distress derived from the COVID-19 crisis. A multicenter …

Catatonia is a neuropsychiatric disorder characterized by motor, affective and cognitive–
behavioural signs, which lasts from hours to days. Intensive research over the past two …